Crisil Merger & Restructuring

Crisil Results Update

Crisil reported Q3 FY27 consolidated income from operations up 20.2% to Rs 1,095.2 crore and PAT up 5.9%. It also declared an interim dividend of Rs 17 per share.

Crisil Dividend

Crisil set October 29, 2026 as the record date for its third interim dividend of Rs 17 per share. Payment is due on or before November 17, 2026.

Crisil Q2 FY27 Results: Net Profit ₹204.6 Cr, Up 6.0% YoY

Crisil Ltd reported revenue from operations of ₹1,095 Cr (+20.2% YoY) and net profit of ₹204.6 Cr (+6.0% YoY) for Q2 FY27.

Key figure

Net profit ₹204.6 Cr · +6.0% YoY

Crisil Other Announcement

Crisil Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI Listing Regulations.

Crisil Board Meeting Date

Crisil Ltd will hold a board meeting on October 23, 2026, to approve Q3 financial results. The board will also consider a third interim dividend for the 2026 fiscal year.

Crisil Annual General Meeting

Crisil Ltd announced the results of its postal ballot, confirming the appointment of Mr. Abhishek Tomar as Non-executive Director. The resolution was passed with requisite majority.

Symphony Merger & Restructuring Worth ₹27 Cr

Symphony will sell its Bodakdev vacant land for ₹27 Crore, versus ₹5.68 Crore book value. Sale deed is expected November 6, 2026; operations are unaffected.

Value

₹27.00 Cr

Juniper Green Energy Merger & Restructuring Worth ₹0.15 Cr

Juniper Green Energy incorporated wholly owned subsidiary Juniper Green Beta Fifteen Private Limited on October 30, 2026. The company subscribed to 1,50,000 shares for Rs.0.15 Crore.

Value

₹0.15 Cr

Oricon Enterprises Merger & Restructuring Worth ₹145 Cr

Oricon Enterprises sold its leasehold land and building to Anand Rathi Towers for Rs.145 Crore. The sale is completed and the buyer is unrelated to promoters.

Value

₹145.0 Cr

Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹0 Cr

Sale of 26% stake in subsidiary Clean Max Alps to Bayer Vapi for ₹0.0026 Crore. The subsidiary contributed no revenue or net worth last financial year.

Value

₹0.00 Cr

Vimta Labs Merger & Restructuring Worth ₹0.08 Cr

Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.

Value

₹0.08 Cr

Weagro Merger & Restructuring Worth ₹0.01 Cr

Weagro will incorporate a wholly-owned Singapore subsidiary, Weagro Pte Ltd, with initial investment up to SGD 100,000. The move expands its agro business into Singapore.

Value

₹0.01 Cr

Execution

Within two months from the date of the Board decision, subject to statutory approvals.